A Phase 2, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Forced-Dose Titration Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults Aged 18-55 Years with Binge Eating Disorder
|Effective start/end date||5/9/11 → 6/13/12|
- Shire Development Inc.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.